몬테루카스트 나트륨 시장 보고서(2026년)

Montelukast sodium is a leukotriene receptor antagonist that works by blocking the effects of leukotrienes, which are responsible for triggering asthma symptoms and allergic reactions. It is used to prevent and manage asthma symptoms and to treat seasonal and perennial allergic rhinitis. Montelukast is generally administered orally, most commonly in tablet form.

The main product types of montelukast sodium include crystal-like, formless, or amorphous forms. Crystal-like forms refer to solid substances with a regular and repeating three-dimensional molecular structure. The available dosage forms include tablets and oral solutions. These formulations are used for various applications such as bronchospasm, allergic coryza, asthma, urticaria, and others.

Tariffs have influenced the montelukast sodium market by increasing costs for imported active pharmaceutical ingredients, intermediates, and formulation excipients. These impacts have been most evident in regions reliant on cross-border api sourcing, particularly North America and Europe importing from Asia. Higher production costs have affected pricing strategies for generic manufacturers. However, tariffs have also encouraged local api manufacturing and regional formulation capabilities, strengthening domestic supply chains.

The montelukast sodium market research report is one of a series of new reports from The Business Research Company that provides montelukast sodium market statistics, including montelukast sodium industry global market size, regional shares, competitors with a montelukast sodium market share, detailed montelukast sodium market segments, market trends and opportunities, and any further data you may need to thrive in the montelukast sodium industry. This montelukast sodium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The montelukast sodium market size has grown strongly in recent years. It will grow from $4.2 billion in 2025 to $4.59 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to longstanding clinical use of montelukast in asthma control, increasing prevalence of allergic respiratory diseases, established safety profile in long-term therapy, widespread physician adoption for maintenance treatment, availability of cost-effective generic versions.

The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $6.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising global burden of asthma and allergic rhinitis, growing pediatric asthma diagnosis rates, increased awareness of non-steroidal asthma therapies, expanding access to respiratory medicines in emerging markets, continued demand for oral maintenance drugs. Major trends in the forecast period include rising demand for leukotriene receptor antagonists in asthma management, growing use of montelukast in allergic rhinitis treatment, expansion of generic montelukast sodium formulations, preference for oral solid dosage forms in chronic respiratory therapy, increased prescriptions for pediatric and adult asthma patients.

The rising prevalence of asthma is expected to drive the growth of the montelukast sodium market in the coming years. Asthma is a long term respiratory condition characterized by inflammation and narrowing of the airways, leading to recurring symptoms such as wheezing, shortness of breath, chest tightness, and coughing. The incidence of asthma is increasing due to factors including environmental pollution, exposure to allergens, genetic susceptibility, urbanization, lifestyle changes, and respiratory infections. Montelukast sodium is used in asthma management as a leukotriene receptor antagonist that helps prevent and control symptoms by blocking leukotrienes, which play a key role in airway inflammation and bronchoconstriction. For example, in October 2024, according to the National Asthma Council, an Australia based non profit organization, Australia recorded 474 asthma related deaths in 2023, including 325 females and 149 males. This figure was nearly the same as the 473 asthma related deaths reported in 2022, indicating a consistent pattern in asthma mortality. Therefore, the increasing prevalence of asthma is contributing to the growth of the montelukast sodium market.

Major companies operating in the montelukast sodium market are focusing on the development of innovative solutions such as combination therapies to offer broader relief from allergy and asthma symptoms and to improve patient adherence. Combination therapies involve the use of two or more medications together in a single treatment regimen to target multiple disease pathways and achieve better therapeutic outcomes. For instance, in October 2025, Cadila Pharmaceuticals Ltd., an India based pharmaceutical company, introduced Dlorfast M tablets, a fixed dose combination containing desloratadine 5 mg and montelukast 10 mg for the treatment of allergic rhinitis and urticaria. This formulation delivers comprehensive symptom control by addressing both histamine and leukotriene pathways in a convenient once daily oral dose, aiming to enhance patient compliance and provide sustained relief with good tolerability.

In April 2024, Apotex Inc., a Canada based pharmaceutical company, acquired Searchlight Pharma Inc. for an undisclosed amount. Through this acquisition, Apotex seeks to expand its presence in the branded and specialty pharmaceuticals segment by incorporating Searchlight's portfolio of innovative and specialty focused products. Searchlight Pharma Inc. is a Canada based specialty branded pharmaceutical company.

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

North America was the largest region in the montelukast sodium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the montelukast sodium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the montelukast sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The montelukast sodium market consists of sales of monteluksast oral granules, chewable tablets, pill organizers, dosing spoons and syringes, and tablet packaging material. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Montelukast Sodium Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses montelukast sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for montelukast sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The montelukast sodium market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Crystal-like; Form-less Or Amorphous
• 2) By Dosage Form: Tablets; Oral Solutions
• 3) By Application: Bronchospasm; Allergic Coryza; Asthma; Urticaria; Other Applications
• Subsegments:
• 1) By Crystal-Like: Monohydrate Crystal; Anhydrous Crystal; Spherical Crystals; Needle-Like Crystals; Polycrystalline Montelukast Sodium
• 2) By Form-Less Or Amorphous: Amorphous Powder; Amorphous Granules; Non-Crystalline Montelukast Sodium
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi Aventis SA; Teva Pharmaceuticals USA Inc.; Hetero Labs Ltd.; Sun Pharma Industries Ltd.; Aurobindo Pharma Limited; Cipla Inc.; Intas Pharmaceuticals Ltd.; Seqens Group; Sanyo Chemical Industries Ltd.; Morepen Laboratories; Neuland Laboratories Ltd.; Medopharm Private Ltd.; BEC Chemicals Pvt. Ltd; Delmar Chemicals Inc.; Kimia Biosciences Ltd.; Ortin Laboratories Ltd.; MSN Laboratories Pvt Ltd.; Vamsi Labs Ltd.; LGM Pharma LLC; HRV Global Life Sciences; Sigmak Lifesciences; Akums Lifesciences Ltd.; Anwita Drugs & Chemicals Pvt Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Montelukast Sodium Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Montelukast Sodium Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Montelukast Sodium Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Montelukast Sodium Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Leukotriene Receptor Antagonists In Asthma Management
  • 4.2.2 Growing Use Of Montelukast In Allergic Rhinitis Treatment
  • 4.2.3 Expansion Of Generic Montelukast Sodium Formulations
  • 4.2.4 Preference For Oral Solid Dosage Forms In Chronic Respiratory Therapy
  • 4.2.5 Increased Prescriptions For Pediatric And Adult Asthma Patients

5. Montelukast Sodium Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Pulmonology Clinics
• 5.4 Allergy Treatment Centers
• 5.5 Homecare Patients

6. Montelukast Sodium Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Montelukast Sodium Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Montelukast Sodium PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Montelukast Sodium Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Montelukast Sodium Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Montelukast Sodium Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Montelukast Sodium Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Montelukast Sodium Market Segmentation

• 9.1. Global Montelukast Sodium Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Crystal-like, Form-less Or Amorphous
• 9.2. Global Montelukast Sodium Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets, Oral Solutions
• 9.3. Global Montelukast Sodium Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications
• 9.4. Global Montelukast Sodium Market, Sub-Segmentation Of Crystal-Like, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monohydrate Crystal, Anhydrous Crystal, Spherical Crystals, Needle-Like Crystals, Polycrystalline Montelukast Sodium
• 9.5. Global Montelukast Sodium Market, Sub-Segmentation Of Form-Less Or Amorphous, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Amorphous Powder, Amorphous Granules, Non-Crystalline Montelukast Sodium

10. Montelukast Sodium Market Regional And Country Analysis

• 10.1. Global Montelukast Sodium Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Montelukast Sodium Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Montelukast Sodium Market

• 11.1. Asia-Pacific Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Montelukast Sodium Market

• 12.1. China Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Montelukast Sodium Market

• 13.1. India Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Montelukast Sodium Market

• 14.1. Japan Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Montelukast Sodium Market

• 15.1. Australia Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Montelukast Sodium Market

• 16.1. Indonesia Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Montelukast Sodium Market

• 17.1. South Korea Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Montelukast Sodium Market

• 18.1. Taiwan Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Montelukast Sodium Market

• 19.1. South East Asia Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Montelukast Sodium Market

• 20.1. Western Europe Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Montelukast Sodium Market

• 21.1. UK Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Montelukast Sodium Market

• 22.1. Germany Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Montelukast Sodium Market

• 23.1. France Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Montelukast Sodium Market

• 24.1. Italy Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Montelukast Sodium Market

• 25.1. Spain Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Montelukast Sodium Market

• 26.1. Eastern Europe Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Montelukast Sodium Market

• 27.1. Russia Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Montelukast Sodium Market

• 28.1. North America Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Montelukast Sodium Market

• 29.1. USA Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Montelukast Sodium Market

• 30.1. Canada Montelukast Sodium Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Montelukast Sodium Market

• 31.1. South America Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Montelukast Sodium Market

• 32.1. Brazil Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Montelukast Sodium Market

• 33.1. Middle East Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Montelukast Sodium Market

• 34.1. Africa Montelukast Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Montelukast Sodium Market, Segmentation By Product, Segmentation By Dosage Form, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Montelukast Sodium Market Regulatory and Investment Landscape

36. Montelukast Sodium Market Competitive Landscape And Company Profiles

• 36.1. Montelukast Sodium Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Montelukast Sodium Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Montelukast Sodium Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi Aventis SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Teva Pharmaceuticals USA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Hetero Labs Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Montelukast Sodium Market Other Major And Innovative Companies

• Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd.

38. Global Montelukast Sodium Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Montelukast Sodium Market

40. Montelukast Sodium Market High Potential Countries, Segments and Strategies

• 40.1 Montelukast Sodium Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Montelukast Sodium Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Montelukast Sodium Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer